FDA clears three labeling supplements for palonosetron, letrozole, carbamazepineSep 17Weekly roundup, 3 itemscarbamazepineletrozole
FDA approves AstraZeneca's Etcamah for HR-positive breast cancerSep 8Regulatory decisionAstraZenecacamizestrant
Novartis: Myfortic label update approved; M.D. Anderson posts endometrial trial resultsJul 31Weekly roundup, 6 itemsabelacimabDDY391
Pfizer wins four Zithromax label updates in one week; two Phase 2 trial results also postedJul 15Weekly roundup, 6 itemsatirmociclibazithromycin
Novartis posts BioItaLEE and China ribociclib results; registers three new studiesJul 10Weekly roundup, 5 itemsalpelisibinclisiran
Novartis: Mayzent label update approved; four real-world studies registered or recruitingJul 2Weekly roundup, 7 itemsalpelisibFludarabine
Sign inSign in